Stage IIIB Lung Cancer AJCC V8: 50 Clinical Trials, Page 1 of 5

1 2 3 4 5

Hide Studies Not Open or Pending


Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy

Condition(s):Metastatic Lung Non-Small Cell Squamous Carcinoma; Metastatic Lung Non-Squamous Non-Small Cell Carcinoma; Stage IIIB Lung Cancer AJCC v8; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8; Unresectable Lung Non-Small Cell Carcinoma; Unresectable Lung Non-Squamous Non-Small Cell CarcinomaLast Updated:August 27, 2020Recruiting

1 2 3 4 5

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.